Physician profile

Daniel G Wagner

Obstetrics & Gynecology · Chesterfield, MO

NPI 1891880191

$5,027.12

in general payments reported to CMS, 2019-2025

42 companies · $543 in 2025

The $543 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,529.21
Education$256.98

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,353.09 2019-2025 Lo Loestrin Fe, Orilissa
Astellas Pharma US INC $471.93 2019-2024 Veozah, Myrbetriq
Allergan, INC. $275.58 2019-2020
Therapeuticsmd, INC. $215.42 2019-2022
Sumitomo Pharma America, INC. $199.48 2023-2025 Myfembree, Gemtesa
Baxter Healthcare $176.89 2022-2023 Perclot
Evofem Biosciences, INC. $165.89 2020-2025 Phexxi, Solosec, Phexx
Amgen INC. $162.37 2019-2024 Evenity, Prolia
Pfizer INC. $153.92 2019-2023
Organon LLC $147.95 2022-2025 Nexplanon
Exact Sciences Corporation $146.23 2023-2025 Cologuard Collection Kit
Bayer Healthcare Pharmaceuticals INC. $144.50 2019-2023
Coopersurgical, INC. $141.38 2022-2024 Paragard T 380a
Hologic Sales and Service, LLC $131.50 2019-2025 Third Wave, Thinprep 2000 Processor, Aptima
Sage Therapeutics, LLC $128.23 2022-2025 Zurzuvae
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Karl Storz Endoscopy-America $87.52 2019
Shield Therapeutics INC $82.84 2024
Mayne Pharma Commercial LLC $80.36 2022-2025
Myovant Sciences INC. $55.60 2021-2022
Cumberland Pharmaceuticals, INC. $52.20 2019-2022
Lupin INC. $49.77 2019-2020
Merck Sharp & Dohme LLC $48.91 2019
Agile Therapeutics, INC. $48.90 2021-2022
Boehringer Ingelheim Pharmaceuticals, INC. $48.62 2023-2024 Jardiance
Sanofi Pasteur INC. $44.03 2025
Exeltis, USA INC. $43.28 2023-2025 Slynd
Aesculap, INC. $41.91 2019-2020
Amag Pharmaceuticals, INC. $39.96 2019
Daiichi Sankyo INC. $36.25 2019
Ethicon US, LLC $35.40 2022
Covidien LP $30.49 2019
Supernus Pharmaceuticals, INC. $25.84 2025 Qelbree
Minerva Surgical, INC $22.94 2023
Mylan Pharmaceuticals INC. $21.30 2022
Biohaven Pharmaceutical Holding Company LTD. $19.89 2022
Medtronic, INC. $19.81 2025 Truclear
Optumhealth Care Solutions, LLC $16.23 2024 Eitan Medical, Vivify Health Care Team Portal 001
Gilead Sciences, INC. $15.30 2019
Scynexis, INC. $14.93 2022
Duchesnay USA Incorporated $14.60 2019
Boston Scientific Corporation $12.85 2019
Meditrina $3.03 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel G Wagner

$5,027.12

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $543 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/131065/daniel-g-wagner

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.